Symptoms Predict Exacerbation Risk in Bronchiectasis, Suggesting Expanded Role for Macrolide Therapy: Study Finds
Spain: A large international study led by Dr. Oriol Sibila and colleagues at the Hospital Clinic, University of Barcelona, has shown that the daily symptom burden in bronchiectasis patients is a strong independent predictor of future exacerbations. The findings, published in The Lancet Respiratory Medicine, also suggest that long-term macrolide treatment could benefit patients with […]